Position in VTRS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,331,966
+$1,184,275 QoQ
Shares Held
83,877
+667.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#291
of 1,020 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
24,261 | $4,088,948 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,216 | $3,368,015 | |
| 3 | VTRS |
Viatris Inc
This page
|
83,877 | $1,331,966 | |
| 4 | HLN |
Haleon plc
|
81,966 | $764,742 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,768 | $737,499 | |
| 6 | ZTS |
Zoetis Inc.
|
9,047 | $650,117 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
39,210 | $628,536 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
126,966 | $534,526 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,331,966 | 83,877 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $147,691 | 10,932 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $48,878 | 3,926 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $601,840 | 60,792 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,453 | 4,866 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $22,489 | 2,582 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,381 | 2,119 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $16,997 | 1,464 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $13,829 | 1,301 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,671 | 140 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,646 | 152 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,190 | 425 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,201 | 421 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,021 | 418 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $4,618 | 415 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $60,210 | 7,067 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $76,493 | 7,306 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $78,640 | 7,228 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $97,754 | 7,225 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $97,885 | 7,224 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $83,453 | 5,840 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $23,987 | 1,280 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||